Top Feature

Oct 16, 2018
Pharmaceutical Executive
Pharm Exec’s 11th annual list profiles the diverse stories of 10 rising biopharma managers—and how each are changing the ways leaders direct critical industry functions.
Oct 15, 2018
Disparities in income levels in China continue to drive far-reaching differences in how poorer and richer cancer patients are treated, with recent data suggesting different outcomes for poorer patients. Pieter De Richter reports.
Oct 10, 2018
Pharmaceutical Executive
A growing range of MBAs with concentrations in pharmaceuticals and healthcare management are on offer. Pharm Exec look at how three of the top programs in the US prepare their students for industry success.
Oct 05, 2018
Pharm Exec speaks to Inovio Pharmaceuticals' Dr. J. Joseph Kim about his journey from humble beginnings as an 11-year-old Korean immigrant to his present position at the forefront of a new medical frontier.
Sep 21, 2018
Pharmaceutical Executive
Pharm Exec talks with CSL's top executive about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.
Sep 20, 2018
Pharmaceutical Executive
While definitions for “specialty drug” vary, this once-niche treatment market may be poised to steer the future of prescription medicine and patient care.
Sep 14, 2018
Pharmaceutical Executive
With specialty companies getting smarter in applying their big data insights to product marketing, the true commercial potential of machine learning and predictive modeling may soon be within reach.
Sep 12, 2018
Pharmaceutical Executive
Pharm Exec’s latest company leaderboard in delivering shareholder value highlights the most critical measure of management performance—return on invested capital.
Aug 30, 2018
Pharm Exec talks to AELIX Therapeutics' Dr. José Luis Cabero about how the career and country shift he made a decade ago have motivated and sustained a new direction in his career.
Aug 24, 2018
Pharmaceutical Executive
Lisa Henderson examines the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
native1_300x100
lorem ipsum